ATE493974T1 - Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung - Google Patents

Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung

Info

Publication number
ATE493974T1
ATE493974T1 AT05785782T AT05785782T ATE493974T1 AT E493974 T1 ATE493974 T1 AT E493974T1 AT 05785782 T AT05785782 T AT 05785782T AT 05785782 T AT05785782 T AT 05785782T AT E493974 T1 ATE493974 T1 AT E493974T1
Authority
AT
Austria
Prior art keywords
tedisamil
sustained release
formulations
oral
gastric retention
Prior art date
Application number
AT05785782T
Other languages
English (en)
Inventor
Johan A Bakker
Winter Marius L De
Santa Fabiano
Original Assignee
Abbott Healthcare Products Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Products Bv filed Critical Abbott Healthcare Products Bv
Application granted granted Critical
Publication of ATE493974T1 publication Critical patent/ATE493974T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05785782T 2004-06-28 2005-06-27 Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung ATE493974T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58279804P 2004-06-28 2004-06-28
EP04102987 2004-06-28
PCT/EP2005/052984 WO2006000583A2 (en) 2004-06-28 2005-06-27 Oral sustained release formulation of tedisamil with gastric retention properties

Publications (1)

Publication Number Publication Date
ATE493974T1 true ATE493974T1 (de) 2011-01-15

Family

ID=35782155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05785782T ATE493974T1 (de) 2004-06-28 2005-06-27 Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung

Country Status (12)

Country Link
EP (1) EP1763338B1 (de)
JP (1) JP2008504250A (de)
KR (1) KR20070028598A (de)
AT (1) ATE493974T1 (de)
AU (1) AU2005256653B2 (de)
CA (1) CA2569919A1 (de)
DE (1) DE602005025767D1 (de)
IL (1) IL179859A0 (de)
MX (1) MXPA06015095A (de)
NO (1) NO20070522L (de)
RU (1) RU2385724C2 (de)
WO (1) WO2006000583A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
KR101050015B1 (ko) * 2007-09-21 2011-07-19 동아제약주식회사 위체류약물전달시스템을 이용한 애엽 추출물의 약학조성물및 이를 이용한 서방성 경구용 제제
DK3354276T3 (da) 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
WO2009157711A2 (ko) * 2008-06-24 2009-12-30 Park Eun-Seok 위장체류형 다공성 정제 및 그의 제조 방법
CA2765033C (en) 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
NZ598922A (en) * 2009-08-31 2014-03-28 Depomed Inc Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
EP2468264A1 (de) * 2010-12-27 2012-06-27 Laboratorios Liconsa, S.A. Orale pharmazeutische Tablette zur gesteuerten Abgabe von Mesalazin und Verfahren zu deren Erhalt
CN103393620B (zh) * 2013-08-05 2016-02-03 青岛市中心医院 一种阿折地平胶囊剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69909801T2 (de) * 1998-09-14 2004-06-03 Ranbaxy Laboratories, Ltd. Oral verabreichtes system zur zeitlich und räumlich gesteuerten arzneistoffabgabe
WO2001010405A1 (en) * 1999-08-04 2001-02-15 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system
JP5049450B2 (ja) * 2000-09-29 2012-10-17 アボツト・ヘルスケア・プロダクツ・ベー・ブイ イオン強度に依存しない徐放性製薬組成物

Also Published As

Publication number Publication date
EP1763338B1 (de) 2011-01-05
KR20070028598A (ko) 2007-03-12
RU2385724C2 (ru) 2010-04-10
WO2006000583A2 (en) 2006-01-05
EP1763338A2 (de) 2007-03-21
DE602005025767D1 (de) 2011-02-17
WO2006000583A3 (en) 2006-10-12
AU2005256653A1 (en) 2006-01-05
IL179859A0 (en) 2007-05-15
RU2007103195A (ru) 2008-08-10
JP2008504250A (ja) 2008-02-14
MXPA06015095A (es) 2007-07-17
CA2569919A1 (en) 2006-01-05
AU2005256653B2 (en) 2010-10-14
NO20070522L (no) 2007-01-26

Similar Documents

Publication Publication Date Title
NO20070522L (no) Oral vedvarende frigivelsesformulering av tedisamil med gastriske bibeholdelsesegenskaper
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
CN102036649A8 (zh) 精氨酸盐及其治疗口腔疾病的用途
MX374396B (es) Rocio de fentanilo sublingual.
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
ECSP088560A (es) Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido
NZ605469A (en) Nalbuphine-based formulations and uses thereof
WO2007143557A3 (en) Compounds and methods for treating mammalian gastrointestinal parasitic infections
NO20062198L (no) Bradykinin B1 reseptorantagonister
ATE437679T1 (de) Wässrige antitranspirant formulierung
EA200702282A1 (ru) Комбинация феррохина и производного артемизинина для лечения малярии
ATE392889T1 (de) Orale antimikrobielle pharmazeutische zusammensetzungen
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
TR201001862A1 (tr) Kontrollü salım gerçekleştiren pramipeksol formülasyonları.
JP2009520694A5 (de)
CY1108501T1 (el) Συνθεση δια την προληψη και θεραπευτικη αγωγη ασθενειων κρυολογηματος
TW200603793A (en) Oral sustained release formulation of tedisamil with gastric retention properties
ATE525064T1 (de) Pharmazeutische zusammensetzung mit desloratadin
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
TR201901012T4 (tr) Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı.
DE602005023742D1 (de) Formulierung von 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-on mit verzögerter freisetzung
CL2020000124A1 (es) Composiciones sólidas orales de betahistina de liberación prolongada no pulsátil.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties